Antipodes Partners LTD Globus Medical Inc Transaction History
Antipodes Partners LTD
- $3.16 Billion
- Q1 2025
A detailed history of Antipodes Partners LTD transactions in Globus Medical Inc stock. As of the latest transaction made, Antipodes Partners LTD holds 1,747 shares of GMED stock, worth $105,413. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,747Holding current value
$105,413% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding GMED
# of Institutions
560Shares Held
109MCall Options Held
186KPut Options Held
67.7K-
Vanguard Group Inc Valley Forge, PA10.9MShares$658 Million0.01% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$624 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X07.01MShares$423 Million0.29% of portfolio
-
State Street Corp Boston, MA3.62MShares$218 Million0.01% of portfolio
-
Burgundy Asset Management Ltd. Toronto, A62.8MShares$169 Million2.22% of portfolio
About GLOBUS MEDICAL INC
- Ticker GMED
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 77,037,200
- Market Cap $4.65B
- Description
- Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...